• Skip to content

Biotech Animated

Biotech Animated | Biotechnology & Life-Science Animation | Beautifully Deliver Your Life-science Company’s Message to a Greater Audience | Biotech Animated is a Life-Science Animation, Advertising Strategy and Business Development Firm

Main navigation

  • Projects
  • About
  • What We Do
  • Our Story
  • Team
  • Join Us
  • Contact Us

Humabodies: Unlocking novel biology with next generation multispecific therapeutics

*Please scroll down to the bottom of the page for the final deliverable.

Project Overview

Crescendo Biologics develops highly differentiated products for cancer therapy using the proprietary Humabody® platform. Humabodies are small, robust protein therapeutics that have fully human VH domains. The origin and size of these Humabodies present distinct advantages over conventional therapeutic antibodies. Crescendo is currently focused on two development programs. These are immuno-oncology modulators and Humabody®-drug conjugates (HDCs).

The objective of this project is to attract the interest of investors, potential partners and potential collaborators. Specifically, video 1 will give an overview of the Humabody® platform.

The target audience will have a scientific background and most likely will be working in the Pharmaceutical industry.

Storyboard

crescendo_video_1_17_06-mp4_000000000

Conventional bispecific antibodies are a powerful treatment option but are challenging to develop using existing technologies.

crescendo_video_1_17_06-mp4_000012805

They are cumbersome to engineer, have bioavailability issues and may simply be too large for key applications.

crescendo_video_1_17_06-mp4_000020796

In contrast, Crescendo’s fully human Humabodies are smaller, more robust, and more easily engineered.

crescendo_video_1_17_06-mp4_000023321

Comprised of the smallest natural antigen-recognition portion of the IgG heavy chain,

crescendo_video_1_17_06-mp4_000034035

Humabody ‘building blocks’ have superior druggability, tunable bioavailability, and can be rapidly assembled into optimally configured therapeutics.

crescendo_video_1_17_06-mp4_000039503

Because Humabodies can be combined into an almost limitless number of multispecific formats,

crescendo_video_1_17_06-mp4_000044059

they can engage therapeutic targets in ways that are fundamentally different from conventional antibodies, unlocking novel biology and expanding how we approach anti-cancer therapeutic development.

crescendo_video_2_17_06-mp4_000061299

Crescendo is creating the next-generation of cancer therapeutics.

crescendo_video_2_17_06-mp4_000069402

To learn more about how we’re developing Humabodies for oncology indications—email info@crescendobiologics.com

Video Final Deliverable

  • Join Us
  • Contact Us

COPYRIGHT © 2023 BIOTECH ANIMATED